HIV-positive trial: Results of the cost-effectiveness analysis (per 1000 pregnant HIV-positive women).

All monetary values are expressed in US$ 2012IPTp = Intermittent Preventive Treatment of malaria in pregnancy; HIV = Human Immunodeficiency VirusMQ = Mefloquine; SP = Sulphadoxine-Phyrimethamine; DALY = Disability-adjusted Life Year.*Incremental net costs are equal to Costs associated with IPTp-MQ minus Health system treatment savings**Net incremental costs per DALY averted are equal to Incremental net costs divided by Number of DALYs avertedHIV-positive trial: Results of the cost-effectiveness analysis (per 1000 pregnant HIV-positive women).